This product is suitable for use with diet control and exercise to improve blood sugar control in adult patients with type 2 diabetes.
Siglitstat is a PPAR full agonist that can simultaneously activate PPARα, γ, and δ receptors, and induce downstream target gene expression related to insulin sensitivity, fatty acid oxidation, energy conversion, and lipid transport, and also inhibits PPARγ receptor phosphorylation associated with insulin resistance.
Let us work together to protect precious health